Current treatment strategies for advanced prostate cancer
K Komura, CJ Sweeney, T Inamoto… - … Journal of Urology, 2018 - Wiley Online Library
During the past decade, treatment strategies for patients with advanced prostate cancer
involving stage IV (T4N0M0, N1M0 or M1) hormone‐sensitive prostate cancer and recurrent …
involving stage IV (T4N0M0, N1M0 or M1) hormone‐sensitive prostate cancer and recurrent …
Management of prostate cancer in elderly patients: recommendations of a task force of the International Society of Geriatric Oncology
JP Droz, G Albrand, S Gillessen, S Hughes, N Mottet… - European urology, 2017 - Elsevier
Context Prostate cancer is the most frequent male cancer. Since the median age of
diagnosis is 66 yr, many patients require both geriatric and urologic evaluation if treatment is …
diagnosis is 66 yr, many patients require both geriatric and urologic evaluation if treatment is …
Survival in patients diagnosed with castration-resistant prostate cancer: a population-based observational study in Sweden
M Aly, A Leval, F Schain, J Liwing… - … Journal of Urology, 2020 - Taylor & Francis
Background: This study investigated prostate cancer (PC)-specific survival and overall
survival (OS) in a population-based castration-resistant PC (CRPC) cohort. Methods: Data …
survival (OS) in a population-based castration-resistant PC (CRPC) cohort. Methods: Data …
Biweekly vs Triweekly Cabazitaxel in Older Patients With Metastatic Castration-Resistant Prostate Cancer: The CABASTY Phase 3 Randomized Clinical Trial
S Oudard, R Ratta, E Voog, P Barthelemy… - JAMA …, 2023 - jamanetwork.com
Importance Many patients 65 years or older with metastatic castration-resistant prostate
cancer (mCRPC) are denied taxane chemotherapy because this treatment is considered …
cancer (mCRPC) are denied taxane chemotherapy because this treatment is considered …
[HTML][HTML] Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age …
D Fialová, B Laffon, V Marinković, L Tasić… - European journal of …, 2019 - Springer
Introduction The importance of rational drug therapy is increasing with the aging of the
population. Since one of the main reasons for inappropriate drug prescribing is also the “age …
population. Since one of the main reasons for inappropriate drug prescribing is also the “age …
Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review
MJ Molina-Garrido, C Guillén-Ponce - The Aging Male, 2017 - Taylor & Francis
The management of prostate cancer in the elderly is a major public health concern in most
countries. Currently, most prostate cancers are diagnosed in elderly males. The elderly …
countries. Currently, most prostate cancers are diagnosed in elderly males. The elderly …
Management of prostate cancer in older patients
S Narita, S Hatakeyama, S Sakamoto… - Japanese journal of …, 2022 - academic.oup.com
The incidence of prostate cancer among older men has increased in many countries,
including Asian countries. However, older patients are ineligible for inclusion in large …
including Asian countries. However, older patients are ineligible for inclusion in large …
Testosterone reduction of≥ 480 ng/dL predicts favorable prognosis of Japanese men with advanced prostate cancer treated with androgen-deprivation therapy
S Yamamoto, S Sakamoto, X Minhui, T Tamura… - Clinical Genitourinary …, 2017 - Elsevier
Introduction Reductions in testosterone concentration play a significant role in the treatment
of prostate cancer. We studied the role of testosterone as a prognostic marker for advanced …
of prostate cancer. We studied the role of testosterone as a prognostic marker for advanced …
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups
B Hoeh, C Würnschimmel, RS Flammia… - The …, 2022 - Wiley Online Library
Abstract Background No North‐American study tested the survival benefit of chemotherapy
in de novo metastatic prostate cancer according to race/ethnicity. We addressed this void …
in de novo metastatic prostate cancer according to race/ethnicity. We addressed this void …
Outcomes in studies regarding older patients with prostate cancer: A systematic review
Introduction Older patients are often deemed ineligible for clinical research, and many
frequently-used endpoints and outcome measures are not as relevant for older patients for …
frequently-used endpoints and outcome measures are not as relevant for older patients for …